Department of Biostatistics & Epidemiology, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73126-0901, USA.
Am J Hematol. 2012 Sep;87(9):848-52. doi: 10.1002/ajh.23262. Epub 2012 Jun 5.
To determine the prevalence of immune thrombocytopenia (ITP) in Oklahoma regardless of age, clinical characteristics, insurance status, and source of health care. Patients with ITP were identified by the administrative code ICD-9-CM 287.3 in Oklahoma hematologists' offices for a 2-year period, 2003-2004. Prevalence was estimated separately for children (<16 years old) and adults because of their distinct clinical characteristics. Oklahoma census data for 2000 was used as the denominator. Eighty-seven (94%) of 93 eligible Oklahoma hematologists participated; 620 patients with ITP were identified. The average annual prevalences were as follows: 8.1 (95% CI: 6.7-9.5) per 100,000 children, 12.1 (95% CI: 11.1-13.0) per 100,000 adults, and 11.2 (95% CI: 10.4-12.0) per 100,000 population. Among children and adults less than age 70 years, the prevalence was greater among women. Among adults aged 70 years and older, the prevalence was greater among men. The highest prevalence of ITP was among men age 80 years and older. These data document for the first time the prevalence of ITP regardless of age, clinical characteristics, insurance status, and source of health care. The methodology developed for this prevalence analysis may be adaptable for epidemiologic studies of other uncommon disorders which lack specific diagnostic criteria and are treated primarily by medical specialists. Am. J. Hematol. 2012. © 2012 Wiley Periodicals, Inc.
确定俄克拉荷马州免疫性血小板减少症(ITP)的流行率,无论年龄、临床特征、保险状况和医疗保健来源如何。通过俄克拉荷马州血液科医生办公室的 ICD-9-CM 287.3 行政代码,在 2003-2004 年的 2 年期间确定 ITP 患者。由于其独特的临床特征,分别为儿童(<16 岁)和成人估计流行率。使用 2000 年的俄克拉荷马州人口普查数据作为分母。87(93 名合格的俄克拉荷马州血液科医生中的 94%)参与;确定了 620 例 ITP 患者。平均年流行率如下:每 100,000 名儿童 8.1(95%CI:6.7-9.5),每 100,000 名成人 12.1(95%CI:11.1-13.0),每 100,000 人 11.2(95%CI:10.4-12.0)。在年龄小于 70 岁的儿童和成人中,女性的患病率更高。在年龄 70 岁及以上的成年人中,男性的患病率更高。ITP 的患病率最高的是 80 岁及以上的男性。这些数据首次记录了 ITP 的流行率,无论年龄、临床特征、保险状况和医疗保健来源如何。为这种流行率分析开发的方法可能适用于缺乏特定诊断标准且主要由医学专家治疗的其他罕见疾病的流行病学研究。Am。J。Hematol。2012.©2012 Wiley Periodicals,Inc.